The Fresenius Company

The Else Kröner-Fresenius-Stiftung is the healthcare group’s largest shareholder. EKFS holds 26.61 per cent (status quo on 31 December 2019) common shares in Fresenius SE & Co. KGaA stock.
Fresenius headquarter

There is no interaction between the foundation’s funding activities and the business activities of the healthcare group. The foundation is a recognised non-profit enterprise and is subject to public regulation of foundations.

Fresenius. From Apothecary to Healthcare Group
Fresenius – a fascinating piece of German economic history! Founded in Frankfurt am Main in 1912, Fresenius has evolved over the decades into a globally-active healthcare group. Today, more than 280,000 people in more than 100 countries work for Fresenius, serving the cause of health.

The years of economic recovery brought international expansion, and the company entered the field of dialysis technology. New developments in pharmacology and medical technology continued to push Fresenius forward. Expansion through acquisitions facilitated the planning, construction and opening of hospitals. Fresenius’ success would not have been possible without the energy and legacy of Else Kröner, who took over the management of the company after the Second World War, and provided it with a dependable partner in the Else Kröner-Fresenius-Stiftung.
More information:


Fresenius headquarter


100 Years Freseniuspdf / 6.31 MB
100th Anniversary Picture Volume